Dalal Nesheiwat

Dalal Nesheiwat has extensive experience in the pharmaceutical industry, specializing in clinical science and medical affairs. With a PharmD from Rutgers University, Dalal has held various leadership roles at companies such as Daiichi Sankyo, LIU Brooklyn, Bristol Myers Squibb, Celgene, KYOWA KIRIN PHARMACEUTICAL DEVELOPMENT LIMITED, and Novartis. Throughout their career, Dalal has focused on oncology, hematology, and other disease areas, leading clinical development teams and overseeing successful FDA submissions. Currently serving as the Vice President, Global Head of Clinical Science at Daiichi Sankyo, Dalal continues to make significant contributions to the field of pharmaceuticals.